Testing Copanlisib as a Potential Targeted Treatment in Cancers With PIK3CA Mutations (MATCH-Subprotocol Z1F)
Clinical trial NCT05490771 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05490771
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-20
- Primary completion
- 2021-01-06
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.